Related references
Note: Only part of the references are listed.Durable Polymer Versus Biodegradable Polymer Drug-Eluting Stents After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome The HOST-REDUCE-POLYTECH-ACS Trial
Hyo-Soo Kim et al.
CIRCULATION (2021)
Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCI
Guillaume Marquis-Gravel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial
Hyo-Soo Kim et al.
LANCET (2020)
2018 ESC/EACTS Guidelines on myocardial revascularization
Franz-Josef Neumann et al.
EUROPEAN HEART JOURNAL (2019)
Risk-Benefit Profile of Longer-Than-1-Year Dual-Antiplatelet Therapy Duration After Drug-Eluting Stent Implantation in Relation to Clinical Presentation A Pairwise Meta-Analysis of 6 Trials and 21 457 Patients
Tullio Palmerini et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2019)
Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting
Francesco Costa et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials
Francesco Costa et al.
LANCET (2017)
Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI
Gennaro Giustino et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Procedural Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention
Emmanouil S. Brilakis et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2015)
Stable coronary artery disease: revascularisation and invasive strategies
Raffaele Piccolo et al.
LANCET (2015)
Endothelialization of drug eluting stents and its impact on dual anti-platelet therapy duration
Anwer Habib et al.
PHARMACOLOGICAL RESEARCH (2015)
World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI
Glenn N. Levine et al.
NATURE REVIEWS CARDIOLOGY (2014)
Coronary Artery Disease in Patients with Chronic Kidney Disease: A Clinical Update
Qiangjun Cai et al.
CURRENT CARDIOLOGY REVIEWS (2013)
Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis
Tullio Palmerini et al.
LANCET (2012)
The Relationship Between Chronic Kidney Disease and SYNTAX Score
Ugur Coskun et al.
ANGIOLOGY (2011)
Impact of the Everolimus-Eluting Stent on Stent Thrombosis A Meta-Analysis of 13 Randomized Trials
Usman Baber et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
The Relationship and Threshold of Stent Length With Regard to Risk of Stent Thrombosis After Drug-Eluting Stent Implantation
Jon Suh et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2010)
Stent Thrombosis
David R. Holmes et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Stenting of complex lesions: an overview
Usman Baber et al.
NATURE REVIEWS CARDIOLOGY (2010)
Predictors of Coronary Stent Thrombosis The Dutch Stent Thrombosis Registry
Jochem W. van Werkum et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Stephen D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)